What is M2I Global's earnings per share (EPS)?

M2I Global (MTWO) reported diluted earnings per share of $-0.01 for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

M2I Global Financials

MTWO

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE November

This page shows M2I Global (MTWO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MTWO FY2025 2026-05-15

Liabilities have compounded far faster than liquid assets, leaving balance-sheet repair dependent on external support rather than operating scale.

From FY2023 to FY2025, cash increased from $48K to $515K, but current liabilities climbed from $1.1M to $7.7M; that is why the current ratio stayed below 0.1x even as the cash balance improved. The less obvious implication is that near-term obligations have been arriving faster than liquidity is being rebuilt.

FY2025 shows a working-capital squeeze: current assets of $618K cover only a small fraction of $7.7M due within a year. That leaves the business operating with very little short-term cushion despite a higher reported cash balance.

The capital structure has weakened across the last three reported years: total liabilities rose from $1.1M in FY2023 to $8.0M in FY2025 while equity moved deeper negative to -$7.4M. Shares outstanding also expanded from 514.3M to 716.3M, so widening the share base has not yet translated into a comfortable balance sheet.

Financial Health Signals

Financial Profile 0/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of M2I Global's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

M2I Global has elevated debt relative to equity (D/E of -1.08), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

M2I Global's current ratio of 0.08 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$-0.01

YoY+0.0%

M2I Global earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$515K

YoY+542.0%

5Y CAGR+114.6%

M2I Global held $515K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

716M

YoY+23.1%

5Y CAGR+170.4%

M2I Global had 716M shares outstanding in fiscal year 2025. This represents an increase of 23.1% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

MTWO Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	$3K+240.0%	$1K	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	$1K	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1.4M	N/A	N/A	$67K+278.1%	$18K-7.1%	$19K
Operating Income	N/A	N/A	N/A	-$66K	N/A	$39K
Interest Expense	$27K0.0%	$27K+151.7%	$11K-84.1%	$67K+278.1%	$18K-7.1%	$19K
Income Tax	N/A	N/A	N/A	N/A	$12K+45.2%	$8K
Net Income	N/A	N/A	N/A	-$66K-472.5%	$18K+192.9%	-$19K
EPS (Diluted)	$-0.010.0%	$-0.010.0%	$-0.010.0%	$-0.01	N/A	N/A

Metric	Q2'26	Q1'26	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$372K	N/A	$405K+14.1%	$355K	N/A	$188K-62.1%	$496K+337.0%	$113K
Operating Income	N/A	N/A	-$1.7M	N/A	N/A	N/A	N/A	N/A
Interest Expense	$6K	N/A	$65K+371.5%	$14K	N/A	$21K-19.1%	$26K+7.8%	$24K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	-$1.8M	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	$0.00	N/A	N/A	$0.00	N/A	N/A	$0.00	$0.00

MTWO Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$618K+622.9%	$85K+77.2%	$48K-61.7%	$126K+546.8%	$19K+66.4%	$12K
Current Assets	$618K+622.9%	$85K+77.2%	$48K+247.2%	$14K-28.7%	$19K+66.4%	$12K
Cash & Equivalents	$515K+542.0%	$80K+66.6%	$48K+42178.1%	$1140.0%	$114-99.0%	$11K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$8.0M+185.6%	$2.8M+157.4%	$1.1M+789.3%	$122K+205.5%	$40K+45.3%	$28K
Current Liabilities	$7.7M+193.3%	$2.6M+140.8%	$1.1M+789.3%	$122K+205.5%	$40K+45.3%	$28K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$7.4M-171.8%	-$2.7M-161.1%	-$1.0M-28951.6%	$4K+117.5%	-$21K-29.7%	-$16K
Retained Earnings	-$13.6M-126.9%	-$6.0M-183.9%	-$2.1M-1608.1%	-$124K-315.9%	$57K+45.2%	$39K

Metric	Q2'26	Q1'26	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$170K-72.4%	$618K+50.3%	$411K+245.3%	$119K+39.3%	$85K+44.0%	$59K-53.6%	$128K+22.3%	$105K
Current Assets	$170K-72.4%	$618K+50.3%	$411K+245.3%	$119K+39.3%	$85K+44.0%	$59K-53.6%	$128K+22.3%	$105K
Cash & Equivalents	$67K-86.9%	$515K+111.3%	$244K+1012.4%	$22K-72.7%	$80K+184.6%	$28K-61.1%	$73K+212.2%	$23K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$8.3M+3.6%	$8.0M+133.0%	$3.4M-5.8%	$3.6M+30.1%	$2.8M+30.8%	$2.1M-13.6%	$2.5M+90.8%	$1.3M
Current Liabilities	$8.3M+7.8%	$7.7M+123.9%	$3.4M-0.2%	$3.4M+31.2%	$2.6M+22.4%	$2.1M-13.6%	$2.5M+90.8%	$1.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$8.1M-9.9%	-$7.4M-144.3%	-$3.0M+14.3%	-$3.5M-29.8%	-$2.7M-30.5%	-$2.1M+11.4%	-$2.3M-96.9%	-$1.2M
Retained Earnings	-$15.5M-13.8%	-$13.6M-33.1%	-$10.2M-39.1%	-$7.4M-22.5%	-$6.0M-21.9%	-$4.9M-17.6%	-$4.2M-48.9%	-$2.8M

MTWO Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	N/A	N/A	N/A	-$13K-137.0%	$35K+279.7%	-$20K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	-$21K	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	$34K+43.4%	$24K-21.4%	$30K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	N/A	-$1.8M-14.4%	-$1.6M-554.5%	-$246K	N/A	N/A	-$193K	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$448K-77.7%	$2.0M+9.1%	$1.8M+705.3%	$228K	N/A	N/A	$242K	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MTWO Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	100.0%	N/A	N/A
Operating Margin	N/A	N/A	N/A	-6644.2%	N/A	N/A
Net Margin	N/A	N/A	N/A	-6644.2%	N/A	N/A
Return on Equity	N/A	N/A	N/A	-1845.1%	N/A	N/A
Return on Assets	N/A	N/A	N/A	-52.8%-144.5pp	91.7%+255.9pp	-164.2%
Current Ratio	0.08+0.0	0.03-0.0	0.04-0.1	0.11-0.4	0.49+0.1	0.42
Debt-to-Equity	-1.08-0.1	-1.03+0.0	-1.05-35.0	33.95+35.9	-1.95-0.2	-1.74
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q3'25	Q2'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	-428.0%	N/A	N/A	N/A	N/A	N/A
Current Ratio	0.02-0.1	0.08-0.0	0.12+0.1	0.030.0	0.030.0	0.03-0.0	0.05-0.0	0.08
Debt-to-Equity	-1.02+0.1	-1.08+0.1	-1.14-0.1	-1.030.0	-1.030.0	-1.03+0.0	-1.05+0.0	-1.09
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$7.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.08), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Graphite One GPHOF

$175.7M

Doubleview Gold Corp DBLVF

$421.6M

Nova Minerals NVAAF

$82.4M

Texas Mineral Res Corp TMRC

$90.1M

Arizona Metals AZMCF

$76.0M

Frequently Asked Questions

What are M2I Global's total assets?

M2I Global (MTWO) had $618K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does M2I Global have outstanding?

M2I Global (MTWO) had 716M shares outstanding as of fiscal year 2025.

What is M2I Global's current ratio?

M2I Global (MTWO) had a current ratio of 0.08 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is M2I Global's debt-to-equity ratio?

M2I Global (MTWO) had a debt-to-equity ratio of -1.08 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is M2I Global's debt-to-equity ratio negative or unusual?

M2I Global (MTWO) has negative shareholder equity of -$7.4M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is M2I Global?

M2I Global (MTWO) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.